3M's Q4 2016 earnings call highlighted solid performance, especially in Industrial, with broad-based growth across geographies.  Management expressed confidence in the 1-3% organic growth guidance for 2017.  However, concerns remain around the Health Care segment's anticipated sales acceleration and Consumer's inventory-related challenges. The outlook seems cautiously optimistic, with significant reliance on growth in developing economies.
[1]
